
Stephanie Hunter-Banks
Director of US Medical Learning and Development at Jazz Pharmaceuticals, CEO of Hunter B Consulting Group, and rare disease patient advocate.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Jul 29, 2026
The Diagnostic Odyssey: What Healthcare Gets Wrong About Patients
T
8:12Tom HickeyHOST
So from your perspective, what does that diagnostic journey really look like for the patients and their families? Can you provide us some insights there?
8:23
I'm a living, breathing example of what it's like to go from what I call able to differently abled.
8:34
I'm still on my rare disease journey after 22 years of noticing initial symptoms of foot drop and muscle weakness.
8:43
My technical diagnosis in my chart is muscular dystrophy, NOS, or not otherwise specified diagnosis.
16 MINS LATER
T
24:43Tom HickeyHOST
So what inspired you to take this step into leadership coaching? Can you help us out with that?
